home

AUPH.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

Comparison for AUPH, Aurinia Pharmaceuticals Inc

The comparison is made between AUPH and the comparison stocks RMT, GAM and CLMT

Sales
companyrevenuegross incomeprofit marginincome before tax
AUPH 34.41M 33.99M 98.78 -25.77M
RMT 0.0 0.0 0.0
GAM 0.0 0.0 0.0
CLMT 2.04B 261.6M 12.84 100.4M

For the financial year Jun 30,23, Aurinia Pharmaceuticals Inc sales were $34.41 million and 94.93% under the average of $679.07 million After cost of goods, and selling and general costs, gross income were $33.99 million and 61.02% lower than the average of $87.2 million The profit margin were a lot and the highest and nan,% higher than the average of nan,%

Assets
In the year ending in Jun 30,23, Aurinia Pharmaceuticals Inc net current assets were $381.6 million and above the other companies and -355.14% higher than the average of -$149.57 million This consists of current assets, which were $423.65 million and 41.96% higher than the average of $298.44 million, less current liabilities, which were $42.05 million and 90.61% under the average of $448.0 million

Contributing to the current assets was Cash and Short term assets which were 85.34% and above the other companies and a lot higher than the average of 0.69%, recievables (were 4.5% and 90.54% under the average of 47.54%) and inventory (were 7.49% and 56.65% below the averarge of 17.28%) Contributing to the current liabilities were accounts payable (were 8.75% and 79.31% under the average of 42.31%) and short term debt (were 2.25% and 56.49% lower than the average of 5.17%)

As a multiple of net assets, current liabilities were 10.77% and nan,% below the averarge of a lot. Current liabilities as days of sales represents were 446.01 and 88.56% higher than CLMT at 236.54.

In terms of days of sales, accounts receivables were 202.03 and 224.22% higher than CLMT at 62.31

Long term assets

In the year ending in Jun 30,23, Aurinia Pharmaceuticals Inc net assets were $390.41 million and 1.79% under the average of $397.53 million This consists of current assets, which were $451.76 million and 67.85% under the average of $1404.99 million, less current liabilities, which were $61.35 million and 93.91% lower than the average of $1007.46 million

Contributing to the total assets were Plant and Equipment (were 0.85% and the highest and nan,% higher than the average of nan,%) and tangible assets(were 86.42% and nan,% under the average of a lot) Contributing to the total libiatilites were long term debt (were 0.0% and lower than the other companies and nan,% lower than the average of $nan,) and

As a multiple of total assets, total liabilities were 13.58% and nan,% above the average of nan,%.

nametotal assetstotal liabscur assetscur liabsdays AR
AUPH 451.76M 61.35M 423.65M 42.05M 202.03
RMT 0.0 0.0 27.65M 23.17M
GAM 1410.17M 19.97M 4.26M 642.61K
CLMT 2.8B 3.0B 863.4M 1320.2M 62.31

Plots

``` ```